Texas Institute for Neurological Disorders

Sherman, Texas

Regional Neurology Group
7 Active TrialsInfusion CenterVirtual CareEst. 1978Large Center
22 MS centers statewide · Ranked #4 in Texas for clinical trials
What kind of place is this?
Comprehensive Care TeamResearch FocusedInfusion On-Site

You’re looking at a regional MS-focused neurology practice with a dedicated clinic for multiple sclerosis care. You can expect specialist visits, MRI studies, infusion treatment, and access to research opportunities. As a multi-site practice, you may need to work with a larger office network for scheduling and follow-up.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access4/5
Support Services3/5
Clinical Trials & Research4/5
Insurance & Navigation Help1/5
Scheduling & Virtual Care4/5

About Texas Institute for Neurological Disorders

This center combines on-site infusions with MS research and virtual care, making it a specialized option for MS care in the Sherman area.

Texas Institute for Neurological Disorders offers MS diagnosis, treatment, MRI studies, and on-site infusions for people living with multiple sclerosis and related conditions. The team treats clinically isolated syndrome, relapsing-remitting MS, secondary progressive MS, and primary progressive MS. You can also ask about research opportunities, since the practice conducts MS clinical research. With 13 locations in a regional network, it serves patients across a wider area while keeping MS care centered in Sherman.

Texas Institute for Neurological Disorders is a regional neurology group in Sherman that provides dedicated care for multiple sclerosis. You'll find an MS clinic, MRI studies, infusion services, and neurologists who focus on MS care. It also offers clinical research and virtual care, giving you access to both treatment and ongoing study opportunities.

Featured Care Team Members

Bharathy Sundaram, M.D., M.D.
Director of the MS Clinic
Multiple Sclerosis
Easwar Sundaram Jr., M.D., M.D.
Multiple Sclerosis
Anu Baweja, M.D., M.D.
Multiple Sclerosis
Uma Saligram, M.D., M.D.
Multiple Sclerosis
Andres Morales, D.O., D.O.
Multiple Sclerosis
Jose Matus, M.D., M.D.
Multiple Sclerosis
Lauri Shebesh, MNSc, AGPCNP-C, MNSc, AGPCNP-C
Adult-Gerontology Primary Care Nurse Practitioner

Specialized Programs

MS clinic
MS research center
Infusion center

Services & Treatments

What They Treat
Multiple sclerosisClinically isolated syndromeRelapsing-remitting MSSecondary progressive MSPrimary progressive MS
How They Treat It
Multiple sclerosis clinicMS diagnosisMS treatmentMRI studiesInfusion servicesClinical researchNeurology careREMS-certified infusionsOfatumumabLemtradaOcrelizumabTeriflunomide
Diagnostics
MRI

Research & Clinical Trials

This center is currently involved in 7 clinical trials — ranked #4 in Texas for active trials

A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
FenebrutinibTeriflunomidePlacebo
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
ACTIVE NOT RECRUITINGPHASE3
OcrelizumabOcrelizumabAntihistamineMethylprednisolone
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
OfatumumabTetanus toxoid (TT) containing vaccine (Td, Tdap)13-valent pneumococcal conjugate vaccine (13-PCV)23-valent pneumococcal polysaccharide vaccine (23-PPV)Seasonal Quadrivalent influenza vaccineKeyhole limpet hemocyanin (KLH) neo-antigen

Insurance & Access

Contact
321 N Highland Avenue Suite 200, Sherman, TX 75092
Insurance & Support

FAQs from Texas Institute for Neurological Disorders

Yes. The Sherman practice operates as a dedicated Multiple Sclerosis Clinic with specialist MS care, infusion services, and clinical research.

You can receive MS diagnosis, MS treatment, MRI studies, infusion services, neurology care, and access to clinical research. The center also offers virtual care.

Yes. The practice has an on-site REMS-certified infusion center for MS infusion therapies such as ocrelizumab and Lemtrada.

The MS team includes Bharathy Sundaram, M.D., who serves as Director of the MS Clinic, along with Easwar Sundaram Jr., M.D., Anu Baweja, M.D., Uma Saligram, M.D., Andres Morales, D.O., Jose Matus, M.D., and Lauri Shebesh, MNSc, AGPCNP-C.

Yes. The practice lists clinical research as one of its services and has a dedicated MS research center. If you are interested in studies, you can ask when you schedule.

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website Book